Prolgolimab

DB16740Investigational

Prolgolimab: Overview.

Mechanism: Pharmacologically active on Programmed cell death protein 1
Curator reviewed

Resolves to

Compound

Clinical / RWD

Targets

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

2ATC codesIncluding every combination product, plus 5 drug categories

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Prolgolimab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.